Topical application of Urolithin A slows intrinsic skin aging and protects from UVB-mediated photodamage: Findings from Randomized Clinical Trials
RNA-seq (gene expression) · human · 57 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 57 samples: 15 × skin_Placebo_T1 vs 14 × skin_Placebo_T2 vs 14 × skin_Mitopure_T1 vs 14 × skin_Mitopure_T2Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE264314_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1101951 and SRA study SRP502600. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 57 samples.
How we read this: 4 replicated groups read from 57 sample titles; they account for 57 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8215912 skin_Placebo_T1_1 skin_Placebo_T1
- GSM8215913 skin_Placebo_T2_1 skin_Placebo_T2
- GSM8215914 skin_Mitopure_T1_1 skin_Mitopure_T1
- GSM8215915 skin_Mitopure_T2_1 skin_Mitopure_T2
- GSM8215916 skin_Mitopure_T1_2 skin_Mitopure_T1
- GSM8215917 skin_Mitopure_T2_2 skin_Mitopure_T2
- GSM8215918 skin_Placebo_T1_2 skin_Placebo_T1
- GSM8215919 skin_Placebo_T2_2 skin_Placebo_T2
- GSM8215920 skin_Mitopure_T1_3 skin_Mitopure_T1
- GSM8215921 skin_Mitopure_T2_3 skin_Mitopure_T2
- GSM8215922 skin_Placebo_T1_3 skin_Placebo_T1
- GSM8215923 skin_Placebo_T2_3 skin_Placebo_T2
- GSM8215924 skin_Placebo_T1_4 skin_Placebo_T1
- GSM8215925 skin_Placebo_T2_4 skin_Placebo_T2
- GSM8215926 skin_Mitopure_T1_4 skin_Mitopure_T1
- GSM8215927 skin_Mitopure_T1_5 skin_Mitopure_T1
- GSM8215928 skin_Mitopure_T2_4 skin_Mitopure_T2
- GSM8215929 skin_Placebo_T1_5 skin_Placebo_T1
- GSM8215930 skin_Placebo_T2_5 skin_Placebo_T2
- GSM8215931 skin_Placebo_T1_6 skin_Placebo_T1
- GSM8215932 skin_Placebo_T2_6 skin_Placebo_T2
- GSM8215933 skin_Mitopure_T1_6 skin_Mitopure_T1
- GSM8215934 skin_Mitopure_T2_5 skin_Mitopure_T2
- GSM8215935 skin_Placebo_T1_7 skin_Placebo_T1
- GSM8215936 skin_Mitopure_T1_7 skin_Mitopure_T1
- GSM8215937 skin_Mitopure_T2_6 skin_Mitopure_T2
- GSM8215938 skin_Mitopure_T1_8 skin_Mitopure_T1
- GSM8215939 skin_Mitopure_T2_7 skin_Mitopure_T2
- GSM8215940 skin_Placebo_T1_8 skin_Placebo_T1
- GSM8215941 skin_Placebo_T2_7 skin_Placebo_T2
- GSM8215942 skin_Mitopure_T1_9 skin_Mitopure_T1
- GSM8215943 skin_Mitopure_T2_8 skin_Mitopure_T2
- GSM8215944 skin_Placebo_T1_9 skin_Placebo_T1
- GSM8215945 skin_Placebo_T2_8 skin_Placebo_T2
- GSM8215946 skin_Mitopure_T1_10 skin_Mitopure_T1
- GSM8215947 skin_Mitopure_T2_9 skin_Mitopure_T2
- GSM8215948 skin_Placebo_T1_10 skin_Placebo_T1
- GSM8215949 skin_Placebo_T2_9 skin_Placebo_T2
- GSM8215950 skin_Placebo_T1_11 skin_Placebo_T1
- GSM8215951 skin_Placebo_T2_10 skin_Placebo_T2
+ 17 more — browse all 57 samples with per-sample file links →
- GSE281263 Identification of a novel PDC-E2 epitope in Primary Biliary Cholangitis and application for engineered Treg therapy 632 samples shares application
- GSE285943 A reference model for circulating hematopoietic stem cells with applications to diagnostics 299 samples shares application
- GSE226054 Comprehensive mRNA-sequencing-based characterization of three HEK-293 cell lines during an rAAV production process for Gene Therapy Applications 120 samples shares application
- GSE266275 A randomized double-blind Phase IIb trial to evaluate the efficacy of ChAd63-KH for the treatment of post kala-azar dermal leishmaniasis 100 samples shares randomized
- GSE240861 Ketogenicdiet versus standard high-carbohydrate nutrition in sepsis: a randomized controlled trial 100 samples shares randomized
- GSE229535 Translational application of pharmacogenomics for refractory lung cancer II 99 samples shares application
- GSE271080 Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2- primary breast cancer 86 samples shares randomized
- GSE278745 The Effects of Refined Carbohydrates on Systemic Immunity: Results from a Randomized Controlled Feeding Trial 84 samples shares randomized
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.